Daniel Isaac, MS, DO
- Assistant Professor
- Division of Hematology and Oncology
- Director of Clinical Trials
- Clinician at Karmanos Cancer Institute at McLaren Greater Lansing
- Clinic Address: Karmanos Cancer Institute of McLaren Greater Lansing, 3520 Forest Road, Lansing, MI 48910
- Clinic Phone: 517-975-9500
- Academic Address: 788 Service Road, B429 Clinical Center
- Academic Phone: 517-353-3128
Academic Support Staff: Beth Moore
For clinical appointments and patient-care questions: please contact Karmanos Cancer Institute at McLaren Greater Lansing at (517) 975-9500
BIO
Dr. Daniel Isaac is an Assistant Professor in the Department of Hematology/Oncology at Michigan State University College of Human Medicine. He earned his Bachelor of Science and Master of Science degrees in mechanical engineering from Michigan State University before completing his Doctor of Osteopathic Medicine (DO) degree at the Virginia Tech – Edward Via College of Osteopathic Medicine in Blacksburg, VA. He completed his residency in Internal Medicine at Oakland University William Beaumont Hospital in Royal Oak, MI, before advancing his expertise through the Hematology/Oncology Fellowship Program at Michigan State University, where he served as the chief fellow and completed his fellowship in 2019.
Dr. Isaac’s research interests are primarily focused on genitourinary and breast cancers, with a specific emphasis on novel biomarkers in prostate cancer. He has been an investigator on multiple research grants related to these areas and continues to advance cancer research through his work. As the Director of Clinical Research for the Division of Hematology/Oncology at the Karmanos Cancer Institute at McLaren Greater Lansing, he has contributed to numerous clinical trials aimed at improving cancer treatment outcomes.
Additionally, Dr. Isaac serves as the Associate Program Director for the Hematology/Oncology Fellowship Program at Michigan State University, where he mentors and guides fellows in their professional development. His leadership extends to the Michigan Society of Hematology and Oncology (MSHO), where he serves on the board and was elected President-Elect in 2024.
EDUCATION AND CERTIFICATION
Medical School: Edward Via College of Osteopathic Medicine, Virginia Tech, Blacksburg, VA
Residency: Internal Medicine, William Beaumont Hospital, Royal Oak, MI
Fellowship: Hematology/Oncology Fellowship Program, Michigan State University, East Lansing, MI
Certifications: